Skip to content
Screener

Total Equity at other companies

Merck & Co. logo
Merck & Co.MRK
$41.93B-14.4%
Zoetis logo
ZoetisZTS
$3.15B-36.7%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$6.59B-2.8%
Neogen logo
NeogenNEOG
$2.1B-21.0%
Balchem logo
BalchemBCPC
$1.29B+6.3%
Petco Health and Wellness Company, Inc. logo
Petco Health and Wellness Company, Inc.WOOF
$1.16B+4.3%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.44B+34.1%
Enterprise value$1.42B+33.1%
P/E15.1×-7.1×
P/S+0.1×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:25 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056280
As ofMarch 31, 2026June 30, 2025
Commitments and contingencies (Note 9)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 20,968,682 and 20,367,574 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively; 30,000,000 Class B shares authorized, 19,596,034 and 20,166,034 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively44
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding
Paid-in capital138,179136,995
Retained earnings336,115272,701
Accumulated other comprehensive loss(112,471)(124,018)
Total stockholders’ equity361,827285,682
Total liabilities and stockholders’ equity$1,445,118$1,360,900

Item 1. Financial Statements (unaudited)

FAQ

What is Phibro Animal Health's total equity?
Phibro Animal Health (PAHC) reported total equity of $361.83M in Q1 2026.
How has Phibro Animal Health's total equity changed year-over-year?
Phibro Animal Health's total equity increased by 36.0% year-over-year, from $265.99M to $361.83M.
What is the long-term trend for Phibro Animal Health's total equity?
Over 4 years (2021 to 2025), Phibro Animal Health's total equity has grown at a 4.6% compound annual growth rate (CAGR), from $238.53M to $285.68M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Phibro Animal Health's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude